| Clinical Trial Name | Clinical Trial Full Title | Principal Investigator | Project site status | Clinical trials gov number |
|---|---|---|---|---|
| (Merck) MK-3475-587 / KEYNOTE 587 | A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial | Tozer, Dr Richard | Open to recruitment | NCT03486873 |
| (CCTG) IND.238 | A Phase II Study of Durvalumab Retreatment in Patients who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity | Ellis, Dr Peter | Open to recruitment | NCT03847649 |
| (HHS) CRUSSH | Stereotactic body radiotherapy (SBRT) boost following urgent 3D conformal radiotherapy in the treatment of metastatic epidural spinal cord compression (SCC): A phase I feasibility trial | Schnarr, Dr Kara | Open to recruitment | NCT03529708 |
| (Bold Therapeutics) BOLD-100-001 / TRIO039 | A Phase 1b Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid Tumours | Juergens, Dr Rosalyn | Open to recruitment | NCT04421820 |
| (Merck) MK-7902-005 / LEAP-005 / E7080-G000-224 | A Multicenter, Open-label Phase 2 Study of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) in Previously Treated Subjects with Selected Solid Tumors (LEAP-005) | Hotte, Dr Sebastien | Suspended/On hold | NCT03797326 |
| (Tesaro) 4010-01-001 / GARNET | A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors | Reade, Dr Clare | Suspended/On hold | NCT02715284 |
| (Astellas) 7465-CL-202 / EV-202 / AST 246014 | An Open-label, Multi-cohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors | Hotte, Dr Sebastien | Suspended/On hold | NCT04225117 |
Find a Trial
Contact Us